DIXARIT

This brand name is authorized in Estonia, South Africa, UK.

Active ingredients

The drug DIXARIT contains one active pharmaceutical ingredient (API):

1	Clonidine UNII W76I6XXF06 - CLONIDINE HYDROCHLORIDE
	Clonidine has been shown to have both central and peripheral sites of action. With long-term treatment clonidine reduces the responsiveness of peripheral vessels to vasoconstrictor and vasodilator substances and to sympathetic nerve stimulation. Early in treatment, however, blood pressure reduction is associated with a central reduction of sympathetic outflow and increased vagal tone.
	Read more about Clonidine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
DIXARIT Coated tablet	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N02CX02	Clonidine	N Nervous system → N02 Analgesics → N02C Antimigraine preparations → N02CX Other antimigraine preparations
Discover more medicines within N02CX02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1725498
GB	Medicines & Healthcare Products Regulatory Agency	161596, 199609
ZA	Health Products Regulatory Authority	E/7.3/139